Navigation Links
HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
Date:2/25/2008

patient division, including corporate overhead. Our condensed consolidated results of operations include overhead costs associated with managing and providing shared services to our surgery centers, outpatient, and diagnostic divisions, even though these divisions qualify as discontinued operations.

The Company expects to file its Form 10-K for the year ended December 31, 2007 this week. When filed, the report can be found on the SEC's website at http://www.sec.gov. The information in this press release is summarized and should be read in conjunction with the Form 10-K for the year ended December 31, 2007, when filed.

HealthSouth Corporation and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

(In Millions)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Net operating revenues $439.0 $422.8 $1,752.5 $1,711.6

Operating expenses:

Salaries and benefits 227.1 212.1 869.1 824.4

Other operating expenses 48.0 50.1 243.3 225.5

General and administrative expenses 27.7 36.9 134.8 144.5

Supplies 25.6 25.4 100.7 100.9

Depreciation and amortization 19.7 23.5 77.5 86.8

Impairment of long-lived assets - 9.7 15.1 9.7

Recovery of amounts due from Richard

M. Scrushy - (12.8) - (47.8)

Occupancy costs 13.9 14.6 52.4 54.5

Provision for doubtful accounts 7.8 19.7 34
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Issues Statement on Medicare Bill and 75% Rule
3. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Date of Third Quarter Earnings Conference Call
6. HealthSouth Corporation Appoints New Member to Board of Directors
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. NHP Reports Fourth Quarter and Full Year 2007 Earnings
9. High Calcium Intake May Not Help Prevent Fractures, Reports The Harvard Health Letter
10. Clarity for Consumers on Botox Complication and Death Reports
11. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Ethiopia (PRWEB) , ... July 28, 2015 , ... ... during U.S. President Barack Obama’s visit to Ethiopia to learn more about the ... the Future Initiative . This initiative focuses on accelerating agricultural development as an ...
(Date:7/28/2015)... ... July 28, 2015 , ... opaJUMP! and O-PA! Performance ... health outcomes associated with its training methods. This company is also the first ... study, conducted in early 2015, training yielded an average 80% improvement in functional ...
(Date:7/28/2015)... ... July 28, 2015 , ... Healthpointe ’s Cosmetic ... returns skin to a smooth state, and reduces the appearance of fine lines and ... only FDA-approved injectable gel to instantly add volume to your cheek area to correct ...
(Date:7/28/2015)... ... July 28, 2015 , ... Bipolar disorder is often associated with ... a few times a year. The World Health Organization (WHO) has reported that bipolar ... of Mental Health reveals that the United States has the highest lifetime rate of ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese ... than they are in the general population. Surviving Mesothelioma has just posted an ... , Researchers at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated ...
Breaking Medicine News(10 mins):Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2
... HealthDay Reporter , FRIDAY, June 24 (HealthDay News) -- Autism ... engineers and computer programmers who have autistic children compared to, ... to those observations. Researchers from Cambridge University in England ... with an autism spectrum disorder in a region of the ...
... News) -- Snacking accounts for 25 percent of the calories ... of those snacking calories, a new study indicates. Since ... that averages 580 calories per day, said Richard D. Mattes, ... West Lafayette, Ind. Because many Americans don,t think about ...
... thousands of tiny worms and a homegrown invention to ... Disease. A team of researchers from the faculties ... $450,000 grant from the Collaborative Health Research Projects program, ... to search for effective new drugs to treat the ...
... , FRIDAY, June 24 (HealthDay News) -- Among U.S. drivers ... positive for drugs, a new study has found. Most commonly, ... such as cocaine and amphetamines, and each of these drugs accounted ... in the July issue of the Journal of Studies on ...
... study confirms that medications with anticholinergic activity, which include ... impairment. The research is also the first to identify ... over-the-counter and prescription sleep aids and incontinence treatments ... the impact of these medications on 13,000 men and ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- ... salad dressing appeal to many, but new evidence indicates that ... foods and that those who can,t may end up eating ... presented at the 2011 Institute of Food Technologists annual meeting ...
Cached Medicine News:Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Drug Use May Play Role in 25% of Driver Deaths, Study Finds 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 3Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3
(Date:7/28/2015)... 28, 2015 Mike Rowe , spokesperson and ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference and ... Las Vegas, Nev. ... Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent ... "unsung heroes" – people whose hard work, sacrifice and value ...
(Date:7/28/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today its results for the second quarter ... Pat Mackin, Chairman, President and Chief Executive Officer, said, ... growth strategy with solid progress on several of our ... transition to a direct sales model in France, advancing ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
...
... contains primers and a FAM-labeled probe that is ... 532-labeled probe to detect Flu B. In addition, ... probe for a separate sample processing control. This ... Alexa 532 and Texas Red reporter dyes such ...
...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: